Dr. Vikas Singhal

According to FutureWise analysis, the nephrology and urology devices market in 2026 is US$ 7.33 billion and is expected to reach US$ 14.68 billion by 2036 at a CAGR of 7.19%.  Growth across the nephrology and urology devices market is fundamentally anchored in the escalating global burden of chronic kidney disease, urological disorders, and kidney stone incidence, all of which sustain considerable demand for sophisticated diagnostic and therapeutic device solutions spanning both inpatient and outpatient healthcare environments. Innovation in medical technology continues to serve as a key market accelerator, with manufacturers channelling development efforts into minimally invasive endoscopic instruments, lithotripsy systems, dialysis equipment, and implantable devices designed to elevate procedural accuracy while simultaneously reducing patient recovery durations and overall hospitalization demands. The worldwide expansion of the aging population is placing ... Continue reading →

According to FutureWise analysis, the Neovaginal Surgery market in 2026 is US$ 1.35 billion, and is expected to reach US$2.02 billion by 2036 at a CAGR of 4.11%. The Neovaginal Surgery market is experiencing growth underpinned by the broadening global acceptance and recognition of gender-affirming care, a growing volume of individuals pursuing vaginoplasty and related reconstructive procedures, and the progressive incorporation of gender-affirming surgeries within public and private healthcare reimbursement structures across multiple countries. The market encompasses several established surgical techniques, including penile inversion vaginoplasty, peritoneal pull-through vaginoplasty, sigmoid colon vaginoplasty, and bowel vaginoplasty. Of these, penile inversion vaginoplasty retains its position as the most widely performed approach, supported by its well-documented outcomes, comparatively lower complication profiles, and extensive familiarity among reconstructive and ... Continue reading →

According to FutureWise analysis, the Neonatal Ventilator market in 2026 is US$ 0.51 billion, and is expected to reach US$0.92 billion by 2036 at a CAGR of 6.08%. Growth in the Neonatal Ventilator market is predominantly driven by the increasing occurrence of neonatal respiratory conditions, including respiratory distress syndrome, bronchopulmonary dysplasia, and transient tachypnea of the newborn. These disorders collectively underscore the need for sophisticated ventilatory support as a critical, life-saving intervention within neonatal intensive care environments. The market is structured around several key product categories, encompassing conventional mechanical ventilators, high-frequency oscillatory ventilators, high-frequency jet ventilators, and non-invasive ventilation solutions such as nasal CPAP and bilevel positive airway pressure systems. Among these, non-invasive ventilation is experiencing growing clinical preference, largely due to its demonstrated capacity to ... Continue reading →

According to FutureWise analysis, the Neonatal Thermoregulation market in 2026 is US$ 0.74 billion, and is expected to reach US$1.23 billion by 2036 at a CAGR of 5.21%. The Neonatal Thermoregulation market is fundamentally shaped by the critical need to sustain optimal body temperature in newborns, especially among premature and low-birth-weight infants who are particularly vulnerable to hypothermia and its associated complications, including respiratory distress, hypoglycemia, and elevated mortality risk. The market encompasses a range of product segments such as radiant warmers, incubators, transport incubators, warmed mattresses, and thermal blankets. Among these, closed incubators command a significant share, owing to their capacity to deliver a precisely regulated, humidified microenvironment that closely replicates intrauterine conditions. Continuous technological progress is meaningfully influencing the market landscape, with manufacturers advancing the development of ... Continue reading →

According to FutureWise analysis, the neonatal seizures drugs market in 2026 is US$0.26 billion, and is expected to reach US$ 0.38 billion by 2036 at a CAGR of 3.87%. Seizures in newborns represent abnormal electrical discharges within the central nervous system, typically presenting as stereotyped muscular movements or autonomic irregularities. Diagnosis is confirmed through electroencephalography, and further investigation is generally warranted to identify underlying causes. The condition is notably prevalent, affecting up to 1.4% of full-term neonates and approximately 20% of premature infants, and may serve as an indicator of a serious underlying illness requiring prompt medical intervention. Due to incomplete myelination and underdeveloped dendrites and synapses in neonates, electrical activity does not propagate efficiently, which explains why the majority of neonatal seizures present as focal rather than generalized events. Managing epilepsy in pediatric populations ... Continue reading →

According to FutureWise analysis, the Neonatal Monitoring Equipment market in 2026 is US$ 8.89 billion, and is expected to reach US$13.97 billion by 2036 at a CAGR of 4.62%. Sustained growth in the Neonatal Monitoring Equipment market is driven by the rising global incidence of preterm and low-birth-weight births, which demand continuous and accurate physiological tracking within neonatal intensive care units. The market spans several core product segments, including pulse oximeters, cardiorespiratory monitors, temperature and blood glucose monitoring devices, and multi-parameter systems. Among these, multi-parameter monitors are witnessing accelerated adoption, largely because of their capacity to track several vital signs simultaneously while easing the clinical burden on healthcare staff. Innovation continues to shape the competitive landscape, with manufacturers embedding wireless connectivity, real-time analytics, and AI-driven alert mechanisms into next-generation devices, ... Continue reading →

According to FutureWise analysis, the neonatal intensive care respiratory devices market in 2026 is US$ 2.53 billion, and is expected to reach US$6.71 billion by 2036 at a CAGR of 10.25%. The neonatal intensive care respiratory devices market growth is driven by rising preterm birth rates globally, increasing investments in neonatal healthcare infrastructure, and technological advancements in non-invasive ventilation and high-frequency oscillatory devices. Growing awareness around neonatal mortality reduction, coupled with supportive government initiatives and expanding NICU facilities across emerging economies, continues to fuel demand. Key product segments include mechanical ventilators, CPAP devices, and oxygen therapy equipment, with mechanical ventilators holding a dominant share owing to their critical role in managing respiratory distress syndrome in newborns. North America currently leads the market, attributed to its well-established healthcare systems, high NICU ... Continue reading →

According to FutureWise analysis, the Neonatal Critical Care Equipment market in 2026 is US$3.55 billion, and is expected to reach US$6.29 billion by 2036 at a CAGR of 5.89% The Neonatal Critical Care Equipment market is likely to be driven by the high prevalence of newborn jaundice, an increase in the number of premature labor, and the launch of novel products for use in Neonatal Intensive Care Units (NICU). According to the World Health Organization (WHO), over 15 million infants are born prematurely each year, with over 1 million dying as a result of preterm complications. One of the most difficult jobs is newborn monitoring. In order to manage neonatal symptoms, better tools must be developed. To meet the growing demand for neonatal critical care equipment, public-private initiatives to improve patient care, notably thermoregulation devices, manufacturers are investing heavily. Fetal and neonatal critical care equipment are medical instruments that assist physicians and ... Continue reading →

According to FutureWise analysis, the neonatal (preterm) infant care market in 2026 is US$3.66 billion, and is expected to reach US$6.41 billion by 2036 at a CAGR of 5.76%.  The Neonatal (Preterm) Infant Care Market is witnessing consistent growth, underpinned by the alarming prevalence of preterm births worldwide. The World Health Organization estimates that nearly 15 million infants are born prematurely each year, generating sustained and significant demand for specialized neonatal care equipment and targeted therapeutic interventions. Concurrent advancements in medical technology — spanning next-generation incubators, advanced respiratory support systems, and sophisticated neonatal monitoring devices — are further propelling market expansion, as hospitals and Neonatal Intensive Care Units (NICUs) continue to upgrade their life-support infrastructure to meet evolving clinical standards. Growing healthcare investment in emerging economies across Asia-Pacific and ... Continue reading →

According to FutureWise analysis, the neglected tropical disease treatment market in 2026 is US$3.47 billion, and is expected to reach US$6.91 billion by 2036 at a CAGR of 7.13%.  Neglected tropical disease treatment market robust growth is driven by intensified global funding commitments from organisations such as the WHO, the Bill & Melinda Gates Foundation, and Gavi, which have collectively channeled billions toward elimination programs targeting diseases such as lymphatic filariasis, leishmaniasis, and schistosomiasis across more than 90 endemic countries. Advances in drug discovery and repurposing strategies — including the development of oral therapeutics and combination therapies — are significantly improving treatment accessibility and patient adherence in resource-limited settings where healthcare infrastructure remains constrained. The growing integration of neglected tropical disease programs within broader universal health coverage ... Continue reading →

According to FutureWise analysis, the negative pressure wound therapy market in 2026 is US$2.99 billion, and is expected to reach US$6.02 billion by 2036 at a CAGR of 7.25%. A vacuum dressing forms the foundation of a wound care approach known as Negative Pressure Wound Therapy (NPWT), designed to accelerate the natural healing process. This technique addresses a broad spectrum of wound types, ranging from pressure ulcers and diabetic foot ulcers to post-surgical wounds. NPWT functions by delivering controlled suction to the wound site through a specially sealed dressing, where the resulting negative pressure draws out excess fluid, stimulates blood circulation, and creates an environment conducive to faster tissue regeneration. The sealed dressing further serves as a protective barrier, shielding the wound from bacterial contamination and external pollutants. This therapy is most commonly indicated for chronic wounds that have shown limited or no response to conventional wound ... Continue reading →

According to FutureWise analysis, the needlestick safety injection devices market is expected to register a CAGR of 6.72% from 2026 to 2036. The needlestick safety injection devices market is projected to grow at a CAGR of 6.72%, reflecting a sustained and steady upward trajectory. This momentum is largely driven by tightening occupational safety mandates, as governments and healthcare authorities across North America and Europe push for the widespread integration of engineered sharps injury protection devices within clinical settings. Heightened awareness among healthcare professionals about the transmission risks associated with bloodborne pathogens including HIV, Hepatitis B, and Hepatitis C continues to bolster demand for retractable syringes, shielded needle systems, and self-blunting technologies. Among the latest advancements, passive safety mechanisms that engage automatically eliminating the need for manual activation — are gaining significant ground, as healthcare ... Continue reading →

According to FutureWise analysis, the Needles market in 2026 is US$10.58 billion, and is expected to reach US$21.74 billion by 2036 at a CAGR of 7.47% The injectable tools known as needles are used in conjunction with injections to administer drugs to the body. They are adjusted in the syringes and used to collect samples and inject different pharmaceutical medications into the body. Needles are used for numerous things, including processing blood, performing dental and surgical procedures, and delivering medications to the body through infusions. It has three sections: a long shaft, an incline, and a central piece, and it fits into the syringe's component. In clinical practice, numerous needle types are frequently used for various operations, including the delivery of medications through different skin layers, aesthetic procedures, and various surgical procedures. As a result, there are many different types of needles available. For administering general medication, ... Continue reading →

According to FutureWise analysis, the Needle-Free IV Connectors market in 2026 is US$1.26 billion, and is expected to reach US$2.89 billion by 2036 at a CAGR of 8.66%.  The Needle-Free IV Connectors Market is experiencing robust growth, fueled by a worldwide push to minimize needlestick injuries as hospitals and clinics increasingly prioritize safer intravenous access practices. Innovations in connector engineering, particularly positive and neutral displacement technologies are improving catheter performance and lowering the risk of catheter-related bloodstream infections (CRBSIs), spurring wider clinical adoption. The rapid expansion of healthcare systems across Asia-Pacific and Latin America, alongside a surge in outpatient care and home-based infusion therapy, is extending market reach well beyond conventional hospital settings. Meanwhile, regulatory frameworks enforced by agencies such as the FDA and OSHA continue to set the tone for procurement strategies, reinforcing ... Continue reading →

According to FutureWise analysis, the Needle-Free Injectors market in 2026 is US$1.56 billion, and is expected to reach US$2.87 billion by 2036 at a CAGR of 6.29%. The needle-free injectors market is experiencing robust growth, driven by several converging factors. Patients are increasingly seeking pain-free methods of drug administration, while the escalating prevalence of chronic conditions such as diabetes and autoimmune disorders has expanded the potential user base. A parallel shift toward self-managed treatment regimens is further accelerating demand for these devices. Technological advancements across jet injection, spring-powered, and laser-driven delivery systems are widening the therapeutic applications of needle-free injectors, spanning vaccine distribution, insulin delivery, and biologic treatments. Growing awareness of the risks associated with needlestick injuries, cross-contamination, and infection transmission in clinical settings continues to strengthen the case ... Continue reading →

According to FutureWise analysis, the Needle-Free Injection System market in 2026 is US$0.25 billion, and is expected to reach US$0.89 billion by 2036 at a CAGR of 13.54%. Needle-free injections may improve safety by eliminating needles from the vaccination process. A jet injector, for instance, creates a fine stream of pressurized liquid that can penetrate the skin, allowing medications and vaccines to be delivered while reducing hazardous waste management costs. The majority of biologic drugs are administered through injection, which poses a risk of needlestick injuries. Pharma companies are addressing this challenge by developing needle-free injectors and self-administered medication-device combination products that are more patient-friendly. The convenience and effectiveness of needle-free injectors such as jet injectors leads to better patient compliance, shorter hospital stays, lower healthcare costs, and are easy to use in home care settings. Self-injection ... Continue reading →

According to FutureWise analysis, the Needle Free Drug Delivery Devices market in 2026 is US$17.20 billion, and is expected to reach US$36.88 billion by 2036 at a CAGR of 7.93%. The needle-free drug delivery devices market stands at the cusp of remarkable growth, shaped by a powerful combination of technological advancement, broadening therapeutic applications, and a global healthcare transition toward safer, more patient-centered approaches to drug administration. Key modalities driving adoption across this space include jet injectors, transdermal patches, pulmonary inhalers, and implantable drug delivery systems each offering unique benefits in dosing accuracy, bioavailability, and patient comfort across a diverse spectrum of therapeutic indications. The rising trend of self-administered biologics and vaccines — accelerated in large part by intensified global immunization initiatives — has meaningfully expanded the commercial opportunity for needle-free delivery ... Continue reading →

According to FutureWise analysis, the needle-free diabetes management market in 2026 is US$ 15.76 billion and is expected to reach US$ 30.28 billion by 2036 at a CAGR of 6.75%.  The needle-free diabetes management market is experiencing strong and sustained growth, driven by a rapidly expanding global diabetic population and a heightened focus on enhancing patient quality of life through less invasive approaches to glucose monitoring and insulin delivery. Among the most impactful innovations advancing this space are continuous glucose monitoring systems and transdermal insulin delivery technologies, which collectively offer patients greater ease of use, stronger treatment adherence, and more stable glycemic control. The considerable psychological toll of daily needle-based injections — encompassing anxiety, needle phobia, and long-term injection fatigue — has emerged as a powerful force redirecting both patient and physician preference toward ... Continue reading →

According to FutureWise analysis, the needle-free blood drawing devices market in 2026 is US$1.18 billion, and is expected to reach US$1.92 billion by 2036 at a CAGR of 4.99% The needle-free blood drawing devices market is on a strong growth trajectory, fueled primarily by patients' growing demand for painless, minimally invasive diagnostics — a preference especially pronounced among children and those with a fear of needles. Significant strides in microfluidic and vacuum-based technologies have enhanced the precision and reliability of needle-free blood collection, establishing these devices as a medically credible substitute for traditional venipuncture. The expanding prevalence of chronic illnesses like diabetes and cardiovascular disease, which require routine blood monitoring, continues to drive interest in more comfortable, repeatable sampling methods. On the innovation front, regulatory backing for novel medical technologies and increased investment in ... Continue reading →

According to FutureWise analysis, the needle destroyer market in 2026 is US$6.87 billion, and is expected to reach US$11.31 billion by 2036 at a CAGR of 5.11%. The needle destroyer market is experiencing sustained growth, largely fueled by an increasing worldwide need for safe and reliable needle disposal methods, especially within healthcare environments where needlestick injuries and the risk of cross-contamination continue to pose serious challenges. The rapid uptake of needle destruction devices across hospitals, clinics, and home care settings is being further reinforced by tightening regulatory frameworks and healthcare waste management mandates in both developed and developing nations. The expanding population of patients managing chronic illnesses most notably diabetes, which requires regular insulin injections is steadily widening the consumer base for these devices, helping to ensure durable long-term demand. At the same time, ongoing innovations in needle ... Continue reading →